Formulation and Evaluation of pH and Enzyme - dependent Metronidazole Tablet for Colon Targeted Drug Delivery System

Authors

  • Shruti Ippalwad
  • Jitendra Shinde
  • Ashok Bhosale

Keywords:

Metronidazole, Amoebic dysentery, In- vitro dissolution, Eudragit s100 pH dependent coating, Guar gum, Stabilty study

Abstract

In this study the formulation of safe and effective Ph and Enzyme dependent coated tablet of Metronidazole was prepared for the effectual treatment of Amoebic Dysentery, Inflammatory bowel diseases. Wet granulation method is used for the formulation of colon targeted pH and Enzyme dependent coated tablet of Metronidazole. Eudragit s-100, HPMCK 4M, Guar gum polymer and Eudragit s100 (pH dependent) This coating material is used for this tablet. This coated tablet evaluated for properties such as average weight, hardness and coat thickness, disintegration, drug content. The produced tablets were subjected to in vitro release experiments for two hr at 100 rpm using 0.1 N HCl and phosphate buffer 6.8 pH for three to five hr. After that 7.4pH phosphate buffer was used and the process was repeated for 24hr. Every formulation’s % weight variation, percentage friability and drug molecule content fall within the bounds set by the united states pharmacopoeia (USP). According to the results, metronidazole would be a promising formulation to accomplish the goal of curing inflammatory bowel disorders and amoebic dysentery without causing any gastric irritation. This would be beneficial for individuals who have a history of ulcerative colitis.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Reddy, S. M., Sinha, V. R., & Reddy, D. S. (1999). Novel oral colon specific drug delivery systems for pharmacotherapy of peptide and non-peptide drugs. Drugs Today, 35, 537–580.

Walsh, J.A., 1986. Problems in recognition and diagnosis of amoebiasis: estimation of the global magnitude of morbidity and mortality. Rev. Infect. Dis. 8, 228–238

World Health Organization, 1997. Amoebiasis. WHO Weekly Epidemiologic Record 72, 97–100.

Tracy, J.W., Webster, L.T. Jr., 1996. Drugs used in the chemotherapy of protozoal infections. In: The Pharmacological Basis of Therapeutics by Goodman & Gilman, ninth ed. McGraw Hill, New York, pp. 995–998 and1012–1015.

Van den Mooter, G., Kinget, R., 1995. Oral colon-specific drug delivery: a review. Drug Delivery 2, 81–93.

Touitou, E., Rubinstein, A., 1986. Targeted enteral delivery of insulin to rats. Int. J. Pharm. 30, 95–99.

Gazzaniga, A., Sangali, M.E., Giordano, M., 1994. Oral Chronotropic® drug delivery systems: achievement of time and/or site specificity. Eur. J. Pharm. BioPharma. 40, 246– 250.

McCoy, J. J., Mann, B. J., & Petri, W. A. Jr. (1994). Adherence and cytotoxicity of Entamoeba histolytica or how lectins let parasites stick around. Infect. Immun., 62, 3045.

Lau, A. H., Lam, N. P., Piscitelli, I., & Danziger, L. H. (1992). Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infective agents. Clin. Pharmacokinetics., 23L, 328–364.

Allen L, Ansel H and Jr. Popovich N. Ansel’s Pharmaceutical Dosage Forms and Drug delivery systems, Baltimore, Md: Lippincott Williams & Wilkins. 8th edition, 2004; 260- 268. 2.

Leon Lachmann, Herbert A. Liberman, Joseph L Kanig. The Theory and Practice of Industrial Pharmacy. Varghese Publishing House, Bombay, 3 rd. edition, 1998: 171, 201- 213, 285-286, 293, 313-314, 400-456. 3.

Chien Y.W. Novel Drug Delivery Systems. Revised and Expanded 2nd Editions: 1992: 1-2, 139-140.

Thakkar H, Patel B, Thakkar S. A Review on Techniques for Oral Bioavailability Enhancement of Drugs. International Journal of Pharmaceutical Sciences Review and Research. 2010;4(3): 203-223 5.

Shekhawat PB, Pokharkar VB. Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles. Acta Pharm Sin B. 2016; 7(3):260-280.

Rao AA, Rao VN, SeethaDevi A, Anil K, Naik VV. Oral Controlled Release Drug Delivery System: An Overview. International Journal of Pharma and Chemical Research.2015; 1(1): 6-15

Downloads

Published

2025-09-22

How to Cite

1.
Ippalwad S, Shinde J, Bhosale A. Formulation and Evaluation of pH and Enzyme - dependent Metronidazole Tablet for Colon Targeted Drug Delivery System. J Neonatal Surg [Internet]. 2025Sep.22 [cited 2025Oct.2];14(19S):1114-22. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/9188

Issue

Vol. 14 No. 19S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.